NCT06385795 - A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

August 13, 2025

Study Completion Date

August 13, 2025

Conditions

Menopause SyndromeMenopauseHot Flashes

Interventions

DRUG

NOE-115

NOE-115 is an investigational monoamine modulator which has potential anti-inflammatory activity.

Trial Locations (5)

Noema PMM-201 Site #101, Atlanta

Noema PMM-201 Site #102, Jacksonville

Noema PMM-201 Site #106, Las Vegas

Noema PMM-201 Site #104, San Diego

Noema PMM-201 Site #103, Seattle